Published in Transplantation on June 15, 2005
Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol (2009) 2.08
Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro. Blood (2008) 1.95
Long-lived autoreactive plasma cells drive persistent autoimmune inflammation. Nat Rev Rheumatol (2011) 1.82
Targeting B cells and antibody in transplantation. Am J Transplant (2011) 1.34
Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation. Cytotherapy (2012) 1.01
Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin. Blood (2005) 0.97
Choice of induction regimens on the risk of cytomegalovirus infection in donor-positive and recipient-negative kidney transplant recipients. Transpl Infect Dis (2010) 0.94
Current and future immunomodulation strategies to restore tolerance in autoimmune diseases. Cold Spring Harb Perspect Biol (2012) 0.91
The generation and maintenance of serum alloantibody. Curr Opin Immunol (2010) 0.88
Recent advances in renal transplantation: antibody-mediated rejection takes center stage. F1000Prime Rep (2015) 0.83
Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients. Transplantation (2014) 0.83
Immune dysregulation in myelodysplastic syndrome. Hematol Rep (2010) 0.82
Haematopoietic stem cell transplantation for autoimmune diseases. Nat Rev Rheumatol (2017) 0.81
Polyclonal antithymocyte globulin and cardiovascular disease in kidney transplant recipients. J Am Soc Nephrol (2014) 0.81
Transgenic rabbits that overexpress the neonatal Fc receptor (FcRn) generate higher quantities and improved qualities of anti-thymocyte globulin (ATG). PLoS One (2013) 0.80
Adult Living Donor Liver Transplantation with ABO-Incompatible Grafts: A German Single Center Experience. J Transplant (2010) 0.79
Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization. Haematologica (2016) 0.78
Antithymocyte globulin facilitates alloreactive T-cell apoptosis by means of caspase-3: potential implications for monitoring rejection-free outcomes. Transplantation (2015) 0.78
Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant. Leuk Lymphoma (2011) 0.77
Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT. Bone Marrow Transplant (2014) 0.77
Lung-Derived Microscaffolds Facilitate Diabetes Reversal after Mouse and Human Intraperitoneal Islet Transplantation. PLoS One (2016) 0.77
A Comparison of Two Types of Rabbit Antithymocyte Globulin Induction Therapy in Immunological High-Risk Kidney Recipients: A Prospective Randomized Control Study. PLoS One (2016) 0.75
B cell repertoires in HLA-sensitized kidney transplant candidates undergoing desensitization therapy. J Transl Med (2017) 0.75
Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant. J Am Soc Nephrol (2016) 0.75
Impact of irradiation and immunosuppressive agents on immune system homeostasis in rhesus macaques. Clin Exp Immunol (2015) 0.75
Immunosuppressive Medications. Clin J Am Soc Nephrol (2015) 0.75
[Immunoablation followed by autologous stem cell transplantation in lupus: a clinical update]. Z Rheumatol (2009) 0.75
Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation. Pediatr Nephrol (2017) 0.75
Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 3.59
Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J Clin Oncol (2004) 3.50
Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology (2005) 2.24
Rab GTPases are recruited to chlamydial inclusions in both a species-dependent and species-independent manner. Infect Immun (2003) 2.10
Impact of center volume on outcomes of increased-risk liver transplants. Liver Transpl (2011) 2.10
A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605. Blood (2011) 1.74
CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells. Blood (2006) 1.65
Hypophosphatemia after 95 right-lobe living-donor hepatectomies for liver transplantation is not a significant source of morbidity. Transplantation (2003) 1.57
Survival after liver transplantation using hepatitis C virus-positive donor allografts: case-controlled analysis of the UNOS database. World J Surg (2011) 1.57
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas. Br J Haematol (2009) 1.57
Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies. Clin Transplant (2006) 1.50
High-throughput flow cytometry data normalization for clinical trials. Cytometry A (2013) 1.47
High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era. Leuk Lymphoma (2011) 1.46
Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization. Vaccine (2010) 1.43
Advances in human B cell phenotypic profiling. Front Immunol (2012) 1.41
TLR-dependent cross talk between human Kupffer cells and NK cells. J Exp Med (2008) 1.37
Pediatric SLE--towards a comprehensive management plan. Nat Rev Rheumatol (2011) 1.29
Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells. J Immunol Methods (2008) 1.28
Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer? Blood (2013) 1.27
Bioinformatic and comparative localization of Rab proteins reveals functional insights into the uncharacterized GTPases Ypt10p and Ypt11p. Mol Cell Biol (2006) 1.26
The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma. Blood (2011) 1.25
Use of intravenous immunoglobulin G (IVIG). Best Pract Res Clin Haematol (2006) 1.22
Modulation of single-cell IgG secretion frequency and rates in human memory B cells by CpG DNA, CD40L, IL-21, and cell division. J Immunol (2009) 1.22
Minimizing morbidity of organ donation: analysis of factors for perioperative complications after living-donor nephrectomy in the United States. Transplantation (2008) 1.20
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review. Leuk Res (2011) 1.17
A renewable source of donor cells for repetitive monitoring of T- and B-cell alloreactivity. Am J Transplant (2005) 1.10
Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma. Br J Haematol (2009) 1.07
Two major autoantibody clusters in systemic lupus erythematosus. PLoS One (2012) 1.04
9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity. PLoS One (2012) 1.02
Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. J Immunol (2013) 1.01
International consensus for provisions of quality-driven care in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2013) 1.00
Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor. Arthritis Res Ther (2011) 1.00
Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus. J Immunol (2013) 1.00
Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A. Blood (2012) 0.98
Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res (2007) 0.98
Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin. Blood (2005) 0.97
Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus. J Rheumatol (2011) 0.96
The faltering solid organ donor pool in the United States (2001-2010). World J Surg (2012) 0.95
Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin. Clin Immunol (2009) 0.95
ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation. Leuk Res (2003) 0.94
Liver transplantation in sickle cell anemia: a case of acute sickle cell intrahepatic cholestasis and a case of sclerosing cholangitis. Transplantation (2005) 0.92
Detection of specific periodontal microorganisms from bacteraemia samples after periodontal therapy using molecular-based diagnostics. J Clin Periodontol (2011) 0.92
Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis. Stem Cell Res (2012) 0.91
Quality of reporting of randomized clinical trials in implant dentistry. A systematic review on critical aspects in design, outcome assessment and clinical relevance. J Clin Periodontol (2012) 0.91
Protein kinase C-associated kinase is required for NF-kappaB signaling and survival in diffuse large B-cell lymphoma cells. Blood (2007) 0.89
Cytotoxicity of algae extracts on normal and malignant cells. Leuk Res Treatment (2011) 0.88
Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis. Arthritis Res Ther (2012) 0.87
University of Wisconsin versus histidine-tryptophan-ketoglutarate for tissue preservation in live-donor liver transplantation. Exp Clin Transplant (2006) 0.87
9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus. Arthritis Rheum (2013) 0.87
Centre volume and resource consumption in liver transplantation. HPB (Oxford) (2012) 0.87
Primary central nervous system post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation. J Neurooncol (2011) 0.86
Stem cell enrichment with selectin receptors: mimicking the pH environment of trauma. Sensors (Basel) (2013) 0.86
Stratifying risk of biliary complications in adult living donor liver transplantation by magnetic resonance cholangiography. Transplantation (2008) 0.85
Hepatic arterial reconstruction in 95 adult right lobe living donor liver transplants: evolution of anastomotic technique. Liver Transpl (2003) 0.85
Current trends and short-term outcomes of live donor nephrectomy: a population-based analysis of the nationwide inpatient sample. World J Surg (2010) 0.84
Discrete event modeling of CD4+ memory T cell generation. J Immunol (2004) 0.84
Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant (2006) 0.84
Is left lobe adult-to-adult living donor liver transplantation ready for widespread use? The US experience (1998-2010). HPB (Oxford) (2012) 0.83
A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia. Leuk Res (2013) 0.83
High mortality in orthotopic liver transplant recipients who require hemodialysis. Clin Transplant (2011) 0.83
Burkitt's leukemia with precursor B-cell immunophenotype and atypical morphology (atypical Burkitt's leukemia/lymphoma): case report and review of literature. Leuk Res (2003) 0.82
Clinical study comparing the efficacy of two denture adhesives in complete denture patients. Int J Prosthodont (2009) 0.81
Pediatric liver and kidney transplantation with allografts from DCD donors: A review of UNOS data. Transplantation (2006) 0.81
Validation of the Pediatric Automated Neuropsychological Assessment Metrics in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2013) 0.81
Effect of centre volume and high donor risk index on liver allograft survival. HPB (Oxford) (2011) 0.80
Effect of systemic antibiotics on clinical and patient-reported outcomes of implant therapy - a multicenter randomized controlled clinical trial. Clin Oral Implants Res (2013) 0.80
Pharmacokinetics of mycophenolic acid in liver transplant patients after intravenous and oral administration of mycophenolate mofetil. Liver Transpl (2007) 0.80
Management of peri-implant mucositis and peri-implantitis. Periodontol 2000 (2014) 0.79
Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma. Radiother Oncol (2012) 0.79
Anti-idiotypic monobodies for immune response profiling. Methods (2012) 0.79
Outcomes in partial liver transplantation: deceased donor split-liver vs. live donor liver transplantation. HPB (Oxford) (2011) 0.79
B cell depletion in lupus and Sjögren's syndrome: an update. Curr Opin Rheumatol (2009) 0.79
Multiparameter flow cytometry and bioanalytics for B cell profiling in systemic lupus erythematosus. Methods Mol Biol (2012) 0.78
Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients. Transplantation (2005) 0.78
Breast augmentation with anatomic implants: a method based on the breast implantation base. Aesthetic Plast Surg (2013) 0.78
Laser-assisted lipolysis for knee remodelling: a prospective study in 30 patients. J Cosmet Laser Ther (2012) 0.78
Protein kinase Cβ is required for lupus development in Sle mice. Arthritis Rheum (2013) 0.78
Mini-BEAM and autologous hematopoietic stem-cell transplant for treatment of post-transplant lymphoproliferative disorders. Am J Hematol (2005) 0.78
Surrogate end points for long-term outcomes in chronic myeloid leukemia. Leuk Lymphoma (2013) 0.77
Pharmacokinetics of mycophenolic acid in live donor liver transplant patients vs deceased donor liver transplant patients. J Clin Pharmacol (2008) 0.77
Functional and Molecular Characteristics of Novel and Conserved Cross-Clade HIV Envelope Specific Human Monoclonal Antibodies. Monoclon Antib Immunodiagn Immunother (2015) 0.77
Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients. Transplantation (2008) 0.77
Comparison of right lobe donor hepatectomy with elective right hepatectomy for other causes in New York. Dig Dis Sci (2010) 0.77
Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction. Liver Transpl (2008) 0.77
A 2-year-old with atypical CML with a t(5;12)(q33;p13) treated successfully with imatinib mesylate. Leuk Res (2004) 0.77
Should trichrome stain be used on all post-liver transplant biopsies with hepatitis C virus infection to estimate the fibrosis score? Liver Transpl (2008) 0.77
It's ALL in the liposomes: vincristine gets a new package. J Clin Oncol (2013) 0.76
Postliver transplantation vascular and biliary surgical anatomy. Tech Vasc Interv Radiol (2007) 0.76
Intravenous mycophenolate mofetil with low-dose oral tacrolimus and steroid induction for live donor liver transplantation. Exp Clin Transplant (2005) 0.76
Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post-liver transplant recipients. Liver Transpl (2006) 0.76
Polysubstance abuse in liver transplant patients and its impact on survival outcome. Exp Clin Transplant (2007) 0.75
Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era. Biol Blood Marrow Transplant (2011) 0.75